Latest filing published 04 Aug 2021 for Immuneering Corp, €4.1M.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -76.3%Entry US$26.97 · Close at T+365 US$6.40
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Robert J. Carpenter: trading record in brief
Robert J. Carpenter (board member) discloses dealings in 2 companies, chiefly Genzyme Corp and Immuneering Corp. The record holds 29 filings, for trades running from 20 April 2007 to 3 August 2021.
On the open market, the record shows 1 purchase worth €4.1M and 10 sales worth €3.8M. The net balance comes to €324k on the buying side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 13 option exercises. So far in 2021, the count stands at 1 purchase and no sales.
On 4 August 2021 came the latest disclosure, an open-market purchase for €4.1M in Immuneering Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Robert J. Carpenter
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 325,000 shares@ US$15.00100.0% of flowClass A Common StockSEC:0001104659-21-099732:1Canonical exit: 1 Nov 2021 (T+90)
- 217,173 sharesClass A Common StockSEC:0001104659-21-099732:0
- 2,375 shares0Genzyme common stock (GENZ)SEC:0001225208-11-011384:0
- 31,825 shares@ US$74.00Genzyme common stock (GENZ)SEC:0001225208-11-011384:2
- 2,500 shares0Genzyme common stock (GENZ)SEC:0001225208-10-015488:0
- 2,500 shares0Genzyme common stock (GENZ)SEC:0001225208-09-013849:0
- 1,000 shares@ US$58.70Genzyme common stock (GENZ)SEC:0001225208-09-013096:0
- 2,500 shares0Genzyme common stock (GENZ)SEC:0001225208-09-013028:0
- 10,000 shares@ US$20.59Genzyme common stock (GENZ)SEC:0001225208-09-012589:0
- 10,000 shares@ US$60.33Genzyme common stock (GENZ)SEC:0001225208-09-012589:1
- 1,452 shares@ US$20.59Genzyme common stock (GENZ)SEC:0001225208-09-012589:2
- 1,452 shares@ US$59.40Genzyme common stock (GENZ)SEC:0001225208-09-012589:3
- 10,000 shares@ US$20.59Genzyme common stock (GENZ)SEC:0001225208-09-012360:0
- 10,000 shares@ US$60.62Genzyme common stock (GENZ)SEC:0001225208-09-012360:1
- 10,000 shares0Genzyme common stock (GENZ)SEC:0001225208-09-012302:0
- 10,000 shares@ US$61.28Genzyme common stock (GENZ)SEC:0001225208-09-012302:1
- 7,452 shares0Genzyme common stock (GENZ)SEC:0001225208-09-012302:2
- 2,548 shares0Genzyme common stock (GENZ)SEC:0001225208-09-012302:3
- 2,548 shares@ US$60.70Genzyme common stock (GENZ)SEC:0001225208-09-012302:4
- 7,452 shares@ US$60.70Genzyme common stock (GENZ)SEC:0001225208-09-012302:5
- 18,543 shares@ US$18.61Genzyme common stock (GENZ)SEC:0000732485-07-000041:0
- 18,543 shares@ US$73.05Genzyme common stock (GENZ)SEC:0000732485-07-000041:1
- 1,219 shares@ US$18.61Genzyme common stock (GENZ)SEC:0000732485-07-000039:0
- 1,219 shares@ US$75.00Genzyme common stock (GENZ)SEC:0000732485-07-000039:1
- 400 shares0Genzyme common stock (GENZ)SEC:0000732485-07-000038:0
25 of 28 declarations
